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Abstract
Technological advances, while providing many benefits, often create circumstances that differ from
the conditions in which we evolved. With the wide-spread adoption of electrical lighting during the
20
th century, humans became exposed to bright and unnatural light at night for the first time in their
evolutionary history. Electrical lighting has led to the wide-scale practice of 24-hour shift-work and
has meant that what were once just “daytime” activities now run throughout the night; in many ways
Western society now functions on a 24-hour schedule. Recent research suggests that this gain in
freedom to function throughout the night may also come with significant repercussions. Disruption of
our naturally evolved light and dark cycles can result in a wide range of physiological and behavioral
changes with potentially serious medical implications. In this article we will discuss several
mechanisms through which light at night may exert its effects on cancer, mood, and obesity, as well as
potential ways to ameliorate the impact of light at night.
Introduction
At different times during our respective childhoods, we
both toured Carlsbad Caverns in New Mexico. As part of
the tour, the lights in the cave were turned off. The
darkness was incredible, engulfing absolutely everything.
In our society, we rarely experience such profound
darkness; every night, our homes, work places, and
streets are brightly illuminated by the glow of electric
lights. We will of course always be naturally illuminated
by the stars and the moon on a clear night, but we can
safely say that most of the light we experience at night is
unnatural.
Humans are diurnal, that is, we evolved to be active
during the day and to sleep at night. As such, we never
developed the ability to see well in the dark. Over time,
we have, however, developed the desire to do more and
more during the time we are awake, be it night or day,
and so we have created an environment that corrects for
our relative night blindness. Since the advent of electrical
lighting around the turn of the 20
th century, humans
have become increasingly exposed to bright and unna-
tural light at night. Urban development has further
exacerbated the issue, with lighting from infrastructure
straying into the atmosphere nightly (Figure 1). Today,
99% of the population in the United States and Europe,
and 62% of the world’s remaining population, are
exposed to this “light pollution” [1]. There is no denying
that the invention of electrical lighting was a boon for
developing industry and technology, allowing the
extension of the workday into the night and boosting
economic development. However, the use of light at
night continues to rapidly increase (by 6% per year) [1]
without thorough (or any) consideration of its biological
implications.
Light at night may appear to be an innocuous environ-
mental manipulation, which may be why it was over-
looked as a significant disease risk factor for many years;
however, because of the profound impact light has on
the circadian system and physiological functions such as
hormone secretion, it is reasonable to conclude that
exposure to light at night likely exerts a significant effect
on many physiological processes. In fact, it is now
evident that exposure to light at night has marked social,
ecological, behavioral, and health consequences. In this
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the maladaptive impact of light at night, with a specific
focus on the physiological and psychological health
consequences.
Light at night and cancer
The detrimental effects of light at night were first
explored by epidemiological studies investigating cancer
risk in shift workers. It began in the late 1970s, when it
was proposed that the pineal gland (which produces the
hormone melatonin, a modulator of sleep/wake pat-
terns) influenced the development of breast cancer [2].
However, it was not until the late 1980s, when Richard
Stevens postulated that night-time light exposure may
represent a risk factor for breast cancer development in
Westernized societies, that research in this area began in
earnest [3]. Fast-forward to today, and there is now
strong epidemiological and experimental work in sup-
port of the hypothesis that light at night impacts breast
cancer risk and development, which will be discussed
below. Indeed, the International Agency on Research on
Cancer has classified shift work as “probably carcino-
genic to humans” and some countries (e.g., Denmark)
have classed breast cancer as an occupational health risk
associated with shift work. More recent studies have also
begun to look at the association between exposure to
light at night in general (outside the context of shift
work) and risk for developing certain types of cancer
such as breast and prostate cancer.
Light exposure during the night may increase breast
cancer risk via several mechanisms. First, light at night
affects certain cancers by decreasing levels of the pineal
hormone melatonin, which is suppressed when an
individual is exposed to light at night. Melatonin is
produced and released primarily during the night, with a
longer night corresponding to an increased duration of
melatonin production, and is important for coordinating
endogenous circadian timing. Melatonin production is
disrupted by light at night, with bright light intensities
suppressing melatonin secretion for the entire night.
Melatonin may influence breast cancer development via
two primary routes: (a) a decrease in melatonin may
increase estrogen/progesterone signaling, two known
breast cancer promoters; and/or (b) melatonin may act
directly on cancer and cancer-fighting cells that have
melatonin receptors, reducing tumor growth. Melatonin
can also affect tumor onset and development via its
actions on oxidative stressors [4].
Despite the fact that the association between light at
night and breast cancer has been known for several
decades, appropriate animal models to study light
exposure at night, and in vitro work to provide direct
causational evidence, have been slow to develop. Blask
et al. made pathbreaking advances in light at night and
cancer research in 2005 by providing direct evidence of
the influence of light at night on breast cancer xenografts
in nude rats [5]. Rats bearing human breast cancer
Figure 1. Satellite image of modern night-time artificial light exposure
Map courtesy of Istituto di Scienza e Tecnologia dell’Inquinamento Luminoso (see [19]). © Royal Astronomical Society. Reproduced from the Monthly
Notices of the RAS with permission from Blackwell Science.
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white fluorescent light intensities during their 12-hour
dark phase, which led to a dose-dependent suppression
in melatonin. As light intensities increased, tumor
growth rates increased and latency to tumor onset
decreased. This dose response of cancer cells to different
intensities of light at night demonstrates how even low
level nocturnal lighting can affect cancer development.
Melatonin receptors are generally found in the brain and
some peripheral tissues; however, it was postulated that
the changes in tumor growth and onset seen here may
be a consequence of melatonin receptors directly embed-
ded on the tumor cells. mRNA for melatonin 1 and 2
receptors (MT1 and MT2, respectively) was characterized
on the human breast cancer xenografts, providing
support that both of these melatonin receptors are
expressed in solid tumors in vivo, meaning that melato-
nin has the ability to directly affect cancer cells.
Importantly, no increase in either serum corticosterone
or estradiol levels (adrenocortical/ovarian hormones
known to influence breast cancer risk) during the dark
was observed, meaning melatonin likely worked directly
on tumor cells, and not via hormones, to modulate
cancer growth.
In the same study, human breast cancer xenografts were
perfused in situ with blood collected from premenopau-
sal female volunteers either during the day, during the
night under darkness, or during the night following
exposure to white light. Melatonin-rich blood collected
during the dark suppressed tumor growth signaling
activity when it was perfused through xenografts,
whereas neither the daytime nor night-time light
exposure blood samples (both melatonin-deficient)
suppressed tumor-mediated signaling, providing further
evidence for the role of melatonin in the incidence and
growth of breast cancer associated with exposure to light
at night.
With the invention of electric lights, daylight hours have
gradually been extended 4–7 hours depending on the
season. As a result, overall melatonin production is
suppressed in most people, not just shift workers. This
marked decrease likely reduces the oncostatic effects of
melatonin, which has led researchers to hypothesize that
light at night may contribute to the increased incidence
of tumors in the general population. To determine
whether general lighting levels outside of a shift-working
population also relate to breast cancer incidence, Kloog
et al. obtained the average night-time illumination levels
from 164 countries using the US Defense Meteorological
Satellite Program, and concurrently evaluated breast
cancer incidence from the GLOBOCAN 2002 database
[6]. Geographic information systems were then used to
match the cancer rates with light at night levels obtained
from the satellite imaging and other relevant socio-
economic data (that could also be important in
explaining variations in cancer rates). A strong correla-
tion was revealed between breast cancer rates and light at
night. This is an important addition to the growing body
of research on light at night and breast cancer because it
demonstrates a population-level trend, whereas previous
analyses examined only specific groups. Women living in
the darkest communities may have prolonged durations
of nightly melatonin, lowering their risk of breast cancer.
Understanding the impact of light on our circadian
clock—the internal oscillator that controls our diurnal
rhythms by using transcriptional-translational feedback
loops involving several clock genes—is critical to fully
understanding the link between light at night and cancer.
This is because circadian clock genes are important
regulators of cell proliferation and apoptosis; therefore,
disturbances of clock function may disrupt cellular
processes that may lead to cancer. The circadian clock
is most potently entrained by light, so when individuals
travel to different time zones or stay out late on the
weekends they disrupt their internal timing. Recent work
in circadian clock gene-mutant mice has supported the
hypothesis that disruption of the circadian clock leads to
increased tumor development [7]. Furthermore, mimick-
ing “jet-lag” in these mice by shifting their light cycle
accelerates tumor development. Taken together, these
studies demonstrate that unnatural light at night can
affect tumor development and growth via several
mechanisms.
Light at night and mood
The prevalence of major depression has also increased in
recent decades. Although recognized factors such as
better diagnoses, changing diagnostic criteria, and diet-
ary changes account for some of the rise in depression
rates, additional variables are likely involved. Depression
represents an interaction between genes and the envir-
onment, and the increased rates of depression are
occurring too quickly to be attributable to changes in
genes only. Thus, it seems reasonable to hypothesize that
recent environmental changes may partially account for
the increasing incidence of depression. Light at night is
one likely environmental candidate, although there are
several others.
Fluctuations in daylight from season to season, abnorm-
alities in the circadian clock, sleep disorders, and shift
work are associated with depression in some subpopula-
tions. At the opposite end of the spectrum to exposure to
too much light (at night), depression is often considered
in the context of individuals who experience too little
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seasonal affective disorder (SAD), a mood disorder in
which depressive symptoms are restricted to a particular
time of year (primarily the winter when day lengths are
short), are often ameliorated by light therapy. In SAD, it
is hypothesized that circadian rhythms are misaligned
and melatonin secretion remains high in the morning.
Thus, morning exposure to bright light truncates mela-
tonin secretion. The susceptibility of some individuals to
changes in day length led us to hypothesize that humans
may also be sensitive to dramatic increases in environ-
mentallighting.Itstands toreason thatadecreaseinlight
during ‘normal’ daylight hours (SAD) and an increase in
light during ‘normal’ night-time hours causes a similar
effect because adaptive processes have optimized the
physiological and behavioral regulation of individuals
according to changing day lengths and circadian cycles,
therefore sudden, prolonged or artificial changes in light
cycles will likely affect mood and behavior.
We originally became interested in how light at night
interacts with mood when a graduate student in our lab
was hospitalized with a Staphylococcus infection. One of
his primary complaints while staying in the hospital was
the high levels of light during the night. Because elevated
rates of depression are common among in-patient
populations, we were curious whether light at night
may be a contributing factor. In our first study on light at
night and depression we worked with male mice that
were housed in either a normal light/dark cycle or in
constant light [8]. Additionally, mice either had access to
an opaque tube, in which they could escape light, or a
clear tube that provided no mechanism for light escape.
After living in these two different conditions for 3 weeks,
we tested the mice for depressive-like behaviors in a
swim test and a sugar water test.
One key symptom in human depression is anhedonia,
which is a failure to engage in activities that the individual
previously deemed pleasurable. Mice that were housed in
constant light drank less sugar water than those in the
normal dark/light phase, indicating an anhedonic
response. Furthermore, mice housed in constant light
with a clear tube showed more depressive-like behavioral
responses in the swim test. Mice housed in constant light
with an opaque tube did not display an increase in
depressive behaviors in the swim test, suggesting that
ability to escape the light by entering the opaque tube
partially reversed the depressive responses.
One key issue with extrapolating our initial study on
light at night and depression in male mice to humans is
that humans are generally not exposed to continuous
bright lighting throughout the day and night like the
mice in the investigation were. Those mice had no
temporal cues to establish time of day, and their
circadian rhythms were likely free running. Furthermore,
depression is almost twofold higher among women as
compared with men [9]. For these reasons, we conducted
a follow-up study in which we evaluated the impact of
dim light at night on depression in female Siberian
hamsters [10]. Hamsters were either housed in a
standard light/dark cycle or a light/dim light cycle in
which they experienced dim light (5 lux) during the dark
phase. Similar to male mice, hamsters chronically
exposed to dim light at night were more immobile in
the swim test (an indication of behavioral despair) and
consumed less sucrose solution. Taken together, these
behavioral responses indicate a depression-like state.
Depression is associated with hippocampal structural
changes, which led us to evaluate neuronal morphology.
Hamsters exposed to dim light at night had reduced
spine density in the hippocampus, which has been
associated with depression in other animal models.
Overall, light at night may alter hippocampal structure
leading to behavioral changes.
It is possible that light at night contributes to depression
via suppressed melatonin. For example, agomelatine, a
melatonin-receptor agonist that also antagonizes seroto-
nin (5-HT2c) receptors, is an effective antidepressant.
However, the male mice used in our initial study do not
produce melatonin, which suggests that melatonin is not
the primary mechanism driving the changes in mood.
Overall, we hypothesize that disruption of the circadian
system may in part lead to differences seen in mood.
Another study, which looked at the behavior of clock-
gene-mutant mice, demonstrated how disruption of the
circadian system can influence mood in general. The
mice in this study displayed many symptoms described
in human mania (often experienced cyclically with
depression in illnesses such as bipolar disorder).
Symptoms included hyperactivity, decreased sleep,
lowered depression-like behavior, lowered anxiety, and
increased motivation for rewarding stimuli such as sugar
and cocaine [11]. However, it is important to note that
animals exposed to dim light at night do not change
activity patterns, so circadian disruption is more likely
occurring at the cellular level.
Light at night and body mass
We first discovered that light at night impacted metabo-
lism serendipitously. While conducting research on light
at night and mood we noticed a strange trend; mice
exposed to light at night were becoming fat. Because of
the rapid increase in obesity paralleling increasing light
levels and the association between shift work and
elevated body mass index (BMI) [12,13], we further
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constant light and dim light at night on metabolic
parameters in mice. Both groups of mice exposed to light
at night (either dim or constant bright) had an increase
in body mass throughout our initial study compared
with mice housed in a standard light/dark cycle, despite
equivalent levels of food intake and total daily activity
[14] (Figure 2). Furthermore, after 4 weeks in their
respective light conditions, light-at-night mice displayed
impaired glucose tolerance, which is indicative of a
prediabetic-like state. Although total daily food intake
and activity were not disrupted, light-at-night mice ate
more food during their rest phase than mice housed in
standard light cycle did in their rest phase. (For both sets
of mice, the rest phase was the daylight phase, as the
mice are nocturnal.) Furthermore, correlation analyses
confirmed that percentage of food consumed during the
day was positively related to increased body mass. In a
follow-up study, restricting food availability to a more
typical time of feeding in light-at-night mice prevented
weight gain, further implicating timing of food intake in
body mass gain.
Light at night may also influence metabolism by suppres-
sing melatonin; however, the influence of melatonin on
our results are unclear because the mouse strain under
study produce very low levels of melatonin. Much as with
our work on light at night and depression, we believe that
the changes in metabolism may be due in part to
disruption of the circadian system. Metabolism and the
circadian clock are intrinsically related, with desynchrony
ofactivityandfoodintakecausingmetabolicadjustments.
For example, building on previous research, Joseph Bass
and colleagues recently demonstrated the importance of
functional cross-talk among clock genes for maintaining
energy homeostasis [15]. Clock-gene-mutant mice have
reduced insulin production and impaired glucose toler-
ance. Furthermore, clock mutations have previously been
Figure 2. Exposure to light at night increases body mass in mice
(A) Mice exposed to either dim light at night (dLAN) or constant light (LL) had increased weight gain relative to mice in a standard light/dark cycle (LD).
dLAN and LL mice also reduced glucose tolerance (see (B)) despite similar levels of activity (see (C)) and total daily food consumption (not shown).
However, mice exposed to LAN consumed significantly more food during the light phase (when mice would generally be resting) than those in a standard
light/dark cycle (see (D)). Adapted from Fonken et al., 2010 [14].
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commonalities in phenotype between mice exposed to
light at night and those with disruption in circadian-
related genes, one may hypothesize that light at night
causes changes in metabolism through dysregulation of
peripheral clock genes.
Recent work with human adipose tissue further supports
the role of clock-gene regulation in body mass main-
tenance and metabolism [17]. Gómez-Abellán et al. [17]
showed that human adipose tissue expresses core
molecular components of the circadian system. Impor-
tantly, the researchers also demonstrated that expression
of one of these critical clock genes, Per2, was inversely
related to waist circumference (which the investigators
used as an indication of “metabolic syndrome”). These
results may begin to formulate a mechanism for the
association between increased BMI and working night
shifts; shift workers often experience significant circadian
disruption, which in turn may result in changes in
internal clock coordination impacting adipose tissue.
Conclusion
A common risk factor in many of the pathologies
associated with exposure to light at night is a change in
immune function, notably inflammatory responses, and
recent research has demonstrated that light at night may
detrimentally affect the immune system [18]. Thus, in
addition to investigating the influence of melatonin and
circadian disruption as mechanisms contributing to the
maladaptive affects of light at night, characterization of
the inflammatory response is also warranted.
One important population that is often neglected when
considering light at night is patients in hospitals. While
multiple epidemiological studies have beenconducted on
nurses, there are no studies on the impact of light at night
on the patients with whom they work. Many in-patients
are already at high risk of increased inflammation and
disrupted physiology, which may be exacerbated by light
at night.
Preventing the general population from excessive exposure
to light at night can be achieved with relatively low-cost
manipulations, such as using curtains to block out street
lights, turning off hallway lights, and removing all light
sources, including televisions and computers, from bed-
rooms. However, these methods do not prevent the
extension of daytime hours that many of us experience,
but by no means do we recommend that everyone go to
bed at sunset. Rather, it may be important for people totry
to keep a consistent schedule and avoid rapid shifts in
their waking hours. This is often unavoidable in shift-
working populations, and there are ongoing studies
currently comparing visual aids that may alleviate some
of the maladaptive effects of exposure to light at night in
shift workers. More specifically, not all lighting has an
equal effect; the intrinsically photosensitive retinal gang-
lion cells that project to the master circadian clock in
the brain contain melanopsin and are most responsive to
the blue region of the visible spectrum (ranging from
450 to 485 nm), with longer wavelengths of lighting
minimally impacting the circadian system. Manipulation
of wavelength may prove effective in blocking out some of
the light-induced physiological changes. Current research
investigating the effectiveness of goggles designed to block
out blue wavelength lighting on preventing light-induced
melatonin suppression is ongoing. Furthermore, work
environments could potentially use lighting sources that
emitlessbluelight,whichunfortunatelyisatoddswiththe
push for energy-saving compact fluorescent bulbs.
Modern society now functions on a 24-hour schedule.
Although there are many economic and other societal
benefits to such a schedule, there is converging evidence
from epidemiological and experimental work that light
at night has unintended, maladaptive consequences. In
many ways, this field of study is just beginning; further
characterization of the impact of light at night is needed
along with effective interventions to ameliorate the
unintended negative effects of light at night on health.
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